Landscapes / Companies
Exelixis not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
6
in active trials · 13 in all
Trials
22 active
35 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Approved | 31 May 2030Phase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 31 May 2030 · Phase 3 trial completes | ||||
| Also tested for | Renal Cell Carcinoma, Hepatocellular Carcinoma and 23 more | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Phase 3 | 15 Dec 2026soonPhase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 15 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Colorectal Cancer, Renal Cell Carcinoma and 32 more | ||||
| Open drug page | |||||
— |
Phase 1 | 23 Nov 2026soonPhase 1 trial completes | |||
| Next date | 23 Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Solid Tumors, Esophageal Squamous Cell Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Apr 2027Phase 1 trial completes | |||
| Next date | 30 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 31 May 2027Phase 1 trial completes | |||
| Next date | 31 May 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, Advanced Solid Tumor and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2027Phase 1 trial completes | |||
| Next date | 30 Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
About
- No active trial
- 7 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021